SKYEPHARMA

SKYEPHARMA Contract Manufacturing & Development (CDMO) Profile

Skyepharma is a France-based CDMO expert in the formulation and manufacturing of complex oral solids (controlled release, multilayer, oncology & HPAPI, controlled substances, rare disease, etc). We also develop our own innovation pipeline with a strong focus on switching biologics from the parenteral routes to an oral administration. Our R&D and manufacturing facility is EU-approved as well as FDA-approved, with a superior inspection track-record.

CDMO Services:
Finished Dosage Forms (Small Molecule Drugs); Biologics; Packaging Solids Analytical Development; Drug Delivery System; Formulation Development; ICH Stability Testing; Process Development

Year Founded: 1993

Head Office: Saint Quentin Fallavier, France

Number of Facilities: 1-2

Facility locations: Europe

Website: Visit the SKYEPHARMA website

Linkedin: Connect on Linkedin

Current Capacity: Skyepharma has enough spare capacity both in R&D and manufacturing to quickly start new projects and support its partners with ambitious time-to-market challenges.